adapalene has been researched along with Hypopharyngeal Cancer in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Asada, Y; Fujii, K; Fujimori, H; Imai, T; Matsuura, K; Mochizuki, M; Morita, S; Nakazato, A; Saijoh, S; Sato, I; Satoh, K; Shibuya-Takahashi, R; Shojaku, H; Sugamura, K; Tamai, K; Yamaguchi, K; Yamazaki, T; Yasuda, J | 1 |
1 other study(ies) available for adapalene and Hypopharyngeal Cancer
| Article | Year |
|---|---|
RELA is required for CD271 expression and stem-like characteristics in hypopharyngeal cancer.
Topics: Adapalene; Cell Proliferation; Humans; Hypopharyngeal Neoplasms; NF-kappa B; Receptors, Nerve Growth Factor; Transcription Factor RelA | 2022 |